Biogen Begins Phase III Felzartamab Study for Third Kidney Disease Kidney Health Biogen Begins Phase III Felzartamab Study for Third Kidney Disease admin July 10, 2025 0 Biogen BIIB initiated dosing in a global, late-stage study of its investigational candidate, felzartamab,... Read More Read more about Biogen Begins Phase III Felzartamab Study for Third Kidney Disease
